Categories: News

Prendio-BioProcure Announce Strategic Partnership with CIC to Accelerate Biotech Growth

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

BOSTON, Jan. 29, 2025 /PRNewswire/ — Prendio-BioProcure, industry leaders in life science procurement solutions, are proud to announce their latest strategic partnership with CIC, a global leader in building innovation ecosystems and providing premium lab spaces. This partnership aims to empower early-stage biotech companies to conduct groundbreaking research as efficiently and effectively as possible by leveraging Prendio-BioProcure’s tailored procurement solutions and CIC’s state-of-the-art lab infrastructure.

With CIC’s lab spaces specifically designed to support life sciences innovation, this collaboration will provide biotech founders with the critical resources they need to focus on discovery and growth. Through this partnership, Prendio-BioProcure will offer CIC’s lab clients access to streamlined procurement applications, preferred supplier networks, and cost saving opportunities honed from years of serving the unique needs of the biotech community.

Built for Life Sciences
CIC’s members will gain access to Prendio-BioProcure’s full suite of procurement solutions which are tailored specifically for the needs of biotech labs. For example, startups developing new biologics can leverage Prendio-BioProcure’s preferred supplier network to source high-quality reagents and lab equipment at competitive prices, while CIC’s labs provide ready-to-use facilities equipped with essential tools for cell culture and molecular biology. Additionally, mid-stage companies expanding their operations can benefit from integrated procurement strategies that streamline large-scale sourcing of consumables and capital equipment, all while staying compliant with industry regulations. This collaboration ensures that biotech companies have the resources and support to tackle their unique challenges at every stage of growth. Together, Prendio-BioProcure and CIC are redefining how innovation and scalability are achieved in the life sciences sector.

Aligning Innovation and Growth 
“We are thrilled to partner with CIC to support the next generation of life science companies,” said Tyler Mizenko, Chief Revenue Officer at Prendio-BioProcure. “By combining CIC’s cutting-edge lab spaces with our unparalleled procurement solutions, we are creating a seamless path for biotechs to achieve their growth milestones faster and more efficiently.” 

A Shared Vision for Biotech Advancement
“At CIC, we are committed to building ecosystems where innovation thrives,” said Kelsey Henderson, Associate Director of Lab Development & Partnerships. “Our partnership with Prendio-BioProcure aligns perfectly with our mission to support groundbreaking work in life sciences by ensuring our clients have access to best-in-class procurement systems and expertise.” 

While this partnership will initially focus on CIC’s flagship lab spaces across key innovation hubs, providing a collaborative foundation to foster life science breakthroughs, the benefits of the partnership are available to all CIC clients across US sites. Together, CIC and Prendio-BioProcure are poised to redefine how biotech companies scale and innovate in an increasingly competitive market. 

About Prendio-BioProcure:
Prendio-BioProcure specializes in procurement solutions for the life sciences industry. Designed specifically for biotechs, their software and services streamline purchasing processes, ensure compliance, and empower companies to focus on their core mission—innovation. For more information visit www.prendio.com and www.bioprocure.com.  

About CIC:
CIC builds and operates a global network of innovation campuses where startups, scale-ups, corporations and public entities connect, work, and grow. Founded in 1999, CIC manages 1.5 million square feet of innovation-focused workspace, laboratories, and event space across North America, Europe and Asia. Additionally, CIC develops bespoke programming, builds and enables industry clusters, and provides world-class district consulting—all focused on advancing innovation. 

Learn more about CIC’s innovation campuses featuring workspace & labs, programming, and events at CIC.com. Follow along on LinkedIn, Instagram, and Facebook. 

Media Contact:
Valerie Podbelski
vpodbelski@prendio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/prendio-bioprocure-announce-strategic-partnership-with-cic-to-accelerate-biotech-growth-302362498.html

SOURCE Prendio-BioProcure

Staff

Recent Posts

Delota Reports Unaudited Fourth Quarter Results

Highlights: Total revenue of $10.3 million for Q4 2025, reflecting YoY growth of 1% from…

27 minutes ago

Change in Management: Exyte announces Katrien Verlinden as new President of its Global Business Unit Advanced Technology Facilities

Katrien Verlinden will take over as President of Exyte's Global Business Unit Advanced Technology Facilities…

1 hour ago

Data4Life releases Data2Evidence as open source: a new chapter for global health research

POTSDAM, Germany, April 2, 2025 /PRNewswire/ -- Data4Life, the nonprofit digital health organization, today announced…

1 hour ago

WELL Health Announces Receipt of MCTO

VANCOUVER, BC, April 1, 2025 /PRNewswire/ - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF)…

7 hours ago

Announcing Helient Technologies

Helient Technologies, LLC launches to deliver scalable cloud and hybrid technology solutions. HADDONFIELD, N.J., April…

7 hours ago

Rapid Dose Therapeutics Corp. Announces Payment in Shares for Quarterly Interest on Secured Debt and Update on Shares for Debt Settlement with Creditors

Burlington, Ontario--(Newsfile Corp. - April 1, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT"…

9 hours ago